Jane Street’s Perspective Therapeutics CATX Stock Holding History

Jane Street’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$204K	Buy	+49,000	New	+$207K	﹤0.01%	10103

Other funds holding CATX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's CATX Position: Q1 2026 in Review

Jane Street sold out of Perspective Therapeutics (CATX) in Q1 2026, closing a stake of 263,995 shares — an estimated $1.12M sold.

Jane Street first reported a position in CATX in Q4 2020 and held it in 15 quarters. The position peaked at $1.13M in Q3 2025. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

Jane Street reported no remaining Perspective Therapeutics position as of Q1 2026 after selling out during the quarter.
Jane Street sold 263,995 Perspective Therapeutics shares in Q1 2026, an estimated $1.12M.
Jane Street first reported a position in Perspective Therapeutics in Q4 2020 and held it in 15 quarters.
Jane Street's Perspective Therapeutics position peaked at $1.13M in Q3 2025.
138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.